Actively Recruiting
Effect of Phlebotomy on Heartrate in Polycythemia Patients
Led by Leiden University Medical Center · Updated on 2024-11-13
10
Participants Needed
1
Research Sites
127 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Single-centre, observational within-subject design: patients that undergo phlebotomies regularly for polycythemia will be measured continuously by wearables one week before until one week after a phlebotomy, for three phlebotomies.
CONDITIONS
Official Title
Effect of Phlebotomy on Heartrate in Polycythemia Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with polycythaemia who require phlebotomy regularly, at least every 4 months
- Adults aged 18 years or older
- Must have a smartphone
- Life expectancy of at least 3 months
You will not qualify if you...
- Poor functional status with ECOG score of 3 or higher
- Known arrhythmias or major heart conduction disorders (except paroxysmal atrial fibrillation)
- Currently hospitalized
- Having a pacemaker
- Secondary polyglobulia caused by smoking or lung problems
- Scheduled for cancer treatments or surgery during study period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
LUMC
Leiden, South Holland, Netherlands
Actively Recruiting
Research Team
R
Rik Tonino, MD
CONTACT
J
Jaap Jan Zwaginga, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here